In a prime position to execute or to be acquired
The first data presented for all adult r/r ALL patients treated in the FELIX phase 2 trial was positively straightforward with i) consistent response rates that compare well to competing therapies, ii) outstanding safety which is superior to competing therapies, and iii) industry standard ability t
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.